Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Merrimack Pharmaceuticals
Special Reports
Where are they now? Tracking down 2011’s Fierce 15
Where are they now? It’s time to check in with the Fierce 15 class of 2011.
Annalee Armstrong
Sep 13, 2021 3:00am
Elevation raises $65M to run tumor-agnostic phase 2
Nov 18, 2020 8:35am
Synlogic hires ex-Alnylam VP to lead medical department
Sep 5, 2019 8:05am
Former Merrimack CEO becomes new Yumanity chief—Chutes & Ladders
Jul 12, 2019 9:30am
After exiting troubled Merrimack, ex-CEO becomes new chief at Yumanity
Jul 10, 2019 9:07am
Merrimack's CEO, CFO and president abandon ship—Chutes & Ladders
Jul 3, 2019 9:30am
